New Leaf Biopharma Opportunities II L.P. 13D and 13G filings for Aravive, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:48 pm Unchanged |
2021-12-31 | 13G | Aravive, Inc. ARAV |
New Leaf Biopharma Opportunities II L.P. | 946,423 4.500% |
0 (Unchanged) |
Filing |